Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Study Phase : Discovery Platform
Sponsor : Servier
Deal Size : Undisclosed
Deal Type : Agreement
Servier and Base4 Expand Partnership to Advance Neuroscience Drug Development
Details : The agreement aims to develop RNA-targeted small molecule therapeutics by leveraging Base4's platform to identify RNA-modulating compounds for neuroscience research.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
January 05, 2024
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Discovery Platform
Sponsor : Servier
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?